Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

p35sheLL
(Plasmid #40626)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 40626 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    p5sheLL
  • Backbone manufacturer
    J.T. Schiller, National Cancer Institute, Bethesda, MD, USA (http://home.ccr.cancer.gov/lco/default.asp)
  • Backbone size w/o insert (bp) 7862
  • Total vector size (bp) 10781
  • Modifications to backbone
    HPV5 L1 and L2 replaced with HPV35 L1 and L2
  • Vector type
    Mammalian Expression
  • Selectable markers
    Zeocin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Low Copy

Gene/Insert 1

  • Gene/Insert name
    HPV35 L1
  • Alt name
    L1 major capsid protein
  • Alt name
    L1
  • Alt name
    HPV 35L1
  • Species
    Human Papillomavirus Type 35
  • Insert Size (bp)
    1509
  • Mutation
    Codon optimized for mammalian expression
  • GenBank ID
    Please see comments below
  • Promoter CMV

Cloning Information for Gene/Insert 1

  • Cloning method Restriction Enzyme
  • 5′ cloning site BspEI (not destroyed)
  • 3′ cloning site PspXI (not destroyed)
  • 5′ sequencing primer CMV-F
  • (Common Sequencing Primers)

Gene/Insert 2

  • Gene/Insert name
    HPV35 L2
  • Alt name
    L2 minor capsid protein
  • Alt name
    L2
  • Alt name
    HPV 35L2
  • Species
    Human Papillomavirus Type 35
  • Insert Size (bp)
    1410
  • Mutation
    Codon optimized for mammalian expression
  • GenBank ID
    Please see comments below
  • Promoter Polio IRES

Cloning Information for Gene/Insert 2

  • Cloning method Restriction Enzyme
  • 5′ cloning site NotI (not destroyed)
  • 3′ cloning site NheI (not destroyed)
  • 5′ sequencing primer Unknown
  • 3′ sequencing primer WPRE-R
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Constructs representing HPV35 (p35sheLL), HPV39 (p39sheLL) and HPV59 (p59sheLL) were generated by the insertion of codon optimized genes (Blue Heron, Inc., Bothell, WA, USA) based upon consensus L1 and L2 amino acid sequences into p5shell (http://home.ccr.cancer.gov/lco/default.asp). The consensus sequences were derived from NCBI database sequences (HPV35: M74117, X74477; HPV39: M62849; HPV59: X77858, EU918767) and contemporary sequences from anonymous, HPVinfected cytology samples (HPV35 L1: JN104062–64; HPV35 L2: JN104065–67; HPV39 L1: JN104068–70; HPV39 L2: JN104071–72; HPV59 L1: JN104073–74; HPV59 L2: JN104075–77).

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    p35sheLL was a gift from Simon Beddows (Addgene plasmid # 40626 ; http://n2t.net/addgene:40626 ; RRID:Addgene_40626)
  • For your References section:

    Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera. Draper E, Bissett SL, Howell-Jones R, Edwards D, Munslow G, Soldan K, Beddows S. Vaccine. 2011 Nov 3;29(47):8585-90. Epub 2011 Sep 21. 10.1016/j.vaccine.2011.09.021 PubMed 21939712